Comorbidity affects all domains of physical function and quality of life in patients with rheumatoid arthritis

被引:103
作者
Radner, Helga [1 ]
Smolen, Josef S. [1 ]
Aletaha, Daniel [1 ]
机构
[1] Med Univ Vienna, Div Rheumatol, Dept Internal Med 3, A-1090 Vienna, Austria
关键词
Rheumatoid arthritis; Comorbidity; Physical function; Disability; Disease activity; DISEASE-ACTIVITY; HEALTH SURVEY; DISABILITY; VALIDATION; MORTALITY; IMPROVEMENT; MORBIDITY; TRIAL; INDEX; SF-36;
D O I
10.1093/rheumatology/keq334
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Methods. In 380 patients with established RA, we quantified comorbidity levels according to the age-adjusted Charlson Comorbidity Index (CCIA) and functional disability by serial measures of the HAQ over 1 year. In a subset of 185 patients, we assessed quality of life using Short Form-36 (SF-36). To analyse the relationship between comorbidities, different activities of daily living and health status, we divided patients into four subgroups of CCIA and performed analysis of variance (ANOVA) and multivariable general linear regression models adjusted for gender, disease duration and disease activity. Results. ANOVA showed significant (P < 0.03) increase of disability within each domain of HAQ with increasing level of comorbidity. Similar results were observed using the physical component score (P = 0.003) of the SF-36 and its domains, whereas mental component score (P = 0.31) and its domains were unaffected by comorbidities. In a sub-analysis stratifying patients into different levels of disease activity, we found increase in almost all domains of HAQ within respective groups of CCIA. Conclusions. Activities of daily living represented by HAQ are equally affected by comorbidities. More generally, health status was only affected with respect to its physical but not its mental domains.
引用
收藏
页码:381 / 388
页数:8
相关论文
共 35 条
[1]   Treatment-related improvement in physical function varies with duration of rheumatoid arthritis: a pooled analysis of clinical trial results [J].
Aletaha, D. ;
Strand, V. ;
Smolen, J. S. ;
Ward, M. M. .
ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (02) :238-243
[2]   The American College of Rheumatology N (ACR-N) debate: going back into the middle of the tunnel? Comment on the articles by Siegel and Zhen and by Boers [J].
Aletaha, D ;
Smolen, JS .
ARTHRITIS AND RHEUMATISM, 2006, 54 (01) :377-378
[3]   Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score [J].
Aletaha, D ;
Nell, VP ;
Stamm, T ;
Uffmann, M ;
Pflugbeil, S ;
Machold, K ;
Smolen, JS .
ARTHRITIS RESEARCH & THERAPY, 2005, 7 (04) :R796-R806
[4]   Laboratory testing in rheumatoid arthritis patients taking disease-modifying antirheumatic drugs: Clinical evaluation and cost analysis [J].
Aletaha, D ;
Smolen, JS .
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2002, 47 (02) :181-188
[5]   Measuring function in rheumatoid arthritis - Identifying reversible and irreversible components [J].
Aletaha, Daniel ;
Smolen, Josef ;
Ward, Michael M. .
ARTHRITIS AND RHEUMATISM, 2006, 54 (09) :2784-2792
[6]   THE AMERICAN-RHEUMATISM-ASSOCIATION 1987 REVISED CRITERIA FOR THE CLASSIFICATION OF RHEUMATOID-ARTHRITIS [J].
ARNETT, FC ;
EDWORTHY, SM ;
BLOCH, DA ;
MCSHANE, DJ ;
FRIES, JF ;
COOPER, NS ;
HEALEY, LA ;
KAPLAN, SR ;
LIANG, MH ;
LUTHRA, HS ;
MEDSGER, TA ;
MITCHELL, DM ;
NEUSTADT, DH ;
PINALS, RS ;
SCHALLER, JG ;
SHARP, JT ;
WILDER, RL ;
HUNDER, GG .
ARTHRITIS AND RHEUMATISM, 1988, 31 (03) :315-324
[7]   GERMAN TRANSLATION AND PSYCHOMETRIC TESTING OF THE SF-36 HEALTH SURVEY - PRELIMINARY-RESULTS FROM THE IQOLA PROJECT [J].
BULLINGER, M .
SOCIAL SCIENCE & MEDICINE, 1995, 41 (10) :1359-1366
[8]  
CALLAHAN LF, 1992, J CLIN EPIDEMIOL, V45, P127
[9]   VALIDATION OF A COMBINED COMORBIDITY INDEX [J].
CHARLSON, M ;
SZATROWSKI, TP ;
PETERSON, J ;
GOLD, J .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1994, 47 (11) :1245-1251
[10]  
CHARLSON ME, 1986, CLIN RES, V34, pA360